Access Denied – Extractive Research & Development in the COVID-19 Pandemic, May 2023
This report, part of the Access Denied series, explores the role that UK public entities have played in supporting the development of COVID-19 tools such as diagnostics, vaccines and treatments. It highlights how the lack of equitable access safeguards across the research and development (R&D) continuum results in the perpetuation of an extractive global health … Continued